Showing 1 - 7 results of 7 for search 'Jana Sopkova-de Oliveira Santos', query time: 0.04s Refine Results
  1. 1
    Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy

    Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy by Cédric Lecoutey, Rémi Legay, Audrey Davis, Jana Sopková-de Oliveira Santos, Patrick Dallemagne, Christophe Rochais

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Computational Tool to Design Small Synthetic Inhibitors Selective for XIAP-BIR3 Domain

    Computational Tool to Design Small Synthetic Inhibitors Selective for XIAP-BIR3 Domain by Marc Farag, Charline Kieffer, Nicolas Guedeney, Anne Sophie Voisin-Chiret, Jana Sopkova-de Oliveira Santos

    Published 2023-06-01
    Get full text
    Article
  3. 3
    Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core

    Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core by Mihaela-Liliana Ţînţaş, Ludovic Peauger, Florent Alix, Cyril Papamicaël, Thierry Besson, Jana Sopková-de Oliveira Santos, Vincent Gembus, Vincent Levacher

    Published 2022-12-01
    Get full text
    Article
  4. 4
    First Synthesis of Racemic <i>Trans</i> Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease

    First Synthesis of Racemic <i>Trans</i> Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease by Benjamin Guieu, Cedric Lecoutey, Rémi Legay, Audrey Davis, Jana Sopkova de Oliveira Santos, Cosimo Damiano Altomare, Marco Catto, Christophe Rochais, Patrick Dallemagne

    Published 2020-12-01
    Get full text
    Article
  5. 5
    Description of Joint Alterations Observed in a Family Carrying p.Asn453Ser <i>COMP</i> Variant: Clinical Phenotypes, In Silico Prediction of Functional Impact on <i>COMP</i> Protein and Stability, and Review of the Literature

    Description of Joint Alterations Observed in a Family Carrying p.Asn453Ser <i>COMP</i> Variant: Clinical Phenotypes, In Silico Prediction of Functional Impact on <i>COMP</i> Protei... by Quitterie Rochoux, Jana Sopkova-de Oliveira Santos, Christian Marcelli, Anne Rovelet-Lecrux, Virginie Chevallier, Jean-Jacques Dutheil, Sylvain Leclercq, Karim Boumédiene, Catherine Baugé, Juliette Aury-Landas

    Published 2021-10-01
    Get full text
    Article
  6. 6
    Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease

    Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer’s Disease by François-Xavier Toublet, Cédric Lecoutey, Julien Lalut, Bérénice Hatat, Audrey Davis, Marc Since, Sophie Corvaisier, Thomas Freret, Jana Sopkova de Oliveira Santos, Sylvie Claeysen, Michel Boulouard, Patrick Dallemagne, Christophe Rochais

    Published 2019-07-01
    Get full text
    Article
  7. 7
    Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands

    Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands by Zhicheng Zhou, Isabelle Staropoli, Anne Brelot, Peggy Suzanne, Aurélien Lesnard, Fanny Fontaine, Serge Perato, Sylvain Rault, Olivier Helynck, Fernando Arenzana-Seisdedos, Jana Sopkova-de Oliveira Santos, Bernard Lagane, Hélène Munier-Lehmann, Philippe Colin

    Published 2023-01-01
    Get full text
    Article

Search Tools: